Clinical Trial Update: Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events [NA]

View source ↗

Summary

A completed clinical trial update examining whether ABCB1 genetic variants influence plasma concentrations of new oral anticoagulants in patients experiencing s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• New oral anticoagulants

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Anticoagulants, Thromboembolism | NA | Status: COMPLETED